Gline Matthew
CIK 1750094
Transactions on file
18
Open-market buys
1
Win rate (buys)
100%
1 scored
Avg % since filing (buys)
+142.1%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-10-20 | 2026-10-16 | ROIV Roivant Sciences Ltd. | OfficerDirector CEO | Tax | 34,638 | $1.16M | +8.8% | open → |
| 2026-10-03 | 2026-09-30 | ROIV Roivant Sciences Ltd. | CEO | Tax | 76,171 | $2.79M | -0.2% | open → |
| 2026-04-20 | 2026-04-16 | ROIV Roivant Sciences Ltd. | OfficerDirector CEO | Sale | 289,774 | $8.45M | +25.1% | open → |
| 2025-01-22 | 2025-01-20 | ROIV Roivant Sciences Ltd. | OfficerDirector CEO | Tax | 11,623 | $129.6K | +227.3% | open → |
| 2025-02-24 | 2025-02-20 | ROIV Roivant Sciences Ltd. | OfficerDirector CEO | Tax | 10,945 | $117.3K | +240.4% | open → |
| 2025-03-24 | 2025-03-20 | ROIV Roivant Sciences Ltd. | OfficerDirector CEO | Tax | 10,945 | $120.1K | +232.6% | open → |
| 2025-04-22 | 2025-04-20 | ROIV Roivant Sciences Ltd. | OfficerDirector CEO | Tax | 10,945 | $111.1K | +259.5% | open → |
| 2025-05-22 | 2025-05-20 | ROIV Roivant Sciences Ltd. | OfficerDirector CEO | Tax | 10,945 | $120.8K | +230.5% | open → |
| 2025-12-17 | 2025-12-15 | ROIV Roivant Sciences Ltd. | CEO | Other | 1,329,325 | $28.82M | +68.3% | open → |
| 2025-12-17 | 2025-12-15 | ROIV Roivant Sciences Ltd. | CEO | Sale | 943,527 | $20.46M | +68.3% | open → |
| 2025-12-17 | 2025-12-15 | ROIV Roivant Sciences Ltd. | CEO | Exer. | 2,272,852 | $28.82M | +187.8% | open → |
| 2025-12-17 | 2025-12-15 | ROIV Roivant Sciences Ltd. | CEO | Other | 797,595 | $17.29M | +68.3% | open → |
| 2025-12-17 | 2025-12-15 | ROIV Roivant Sciences Ltd. | CEO | Sale | 566,116 | $12.27M | +68.3% | open → |
| 2025-12-17 | 2025-12-15 | ROIV Roivant Sciences Ltd. | CEO | Exer. | 1,363,711 | $17.29M | +187.8% | open → |
| 2025-12-17 | 2025-12-15 | ROIV Roivant Sciences Ltd. | CEO | Other | 3,739 | $81.1K | +68.3% | open → |
| 2025-12-17 | 2025-12-15 | ROIV Roivant Sciences Ltd. | CEO | Sale | 230,357 | $4.99M | +68.3% | open → |
| 2025-12-17 | 2025-12-15 | ROIV Roivant Sciences Ltd. | CEO | Exer. | 234,096 | $950.4K | +798.8% | open → |
| 2025-09-18 | 2025-09-18 | ROIV Roivant Sciences Ltd. | OfficerDirector CEO | Buy | 3,315 | $50.0K | +142.1% | open → |
